Solv Health was founded in 2016 to empower consumers by simplifying their day-to-day healthcare needs. This is done by bringing convenient and high-quality healthcare to the community. They have done this by having access to health care providers, simplifying the process, and aiming to educate the community on insurance coverage and costs.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/02/2021 | Series C | $45MM | $xx.xx | $399.84MM | Acrew Capital, Benchmark Capital, Corner Ventures, Greylock Partners | |
Price per Share
$xx.xx
Shares Outstanding
10,327,543
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Acrew Capital, Benchmark Capital, Corner Ventures, Greylock Partners
|
||||||
11/12/2020 | Series B-3 | $7MM | $xx.xx | $146.67MM | Acrew Capital, Benchmark, Greylock Partners, Light Street Capital, Multicare Health System | |
Price per Share
$xx.xx
Shares Outstanding
3,452,731
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Acrew Capital, Benchmark, Greylock Partners, Light Street Capital, Multicare Health System
|
||||||
11/12/2020 | Series B-2 | $20MM | $xx.xx | $146.67MM | Acrew Capital, Benchmark, Greylock Partners, Light Street Capital, Multicare Health System | |
Price per Share
$xx.xx
Shares Outstanding
12,824,456
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Acrew Capital, Benchmark, Greylock Partners, Light Street Capital, Multicare Health System
|
||||||
05/08/2018 | Series B | $16.8MM | $xx.xx | $68.63MM | Aspect Ventures, Benchmark, Greylock Partners | |
Price per Share
$xx.xx
Shares Outstanding
12,789,279
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Aspect Ventures, Benchmark, Greylock Partners
|
||||||
04/19/2017 | Series A | $6.25MM | $xx.xx | $20.83MM | Aspect Ventures, Benchmark, Malay Gandhi, Paul Levine | |
Price per Share
$xx.xx
Shares Outstanding
10,722,240
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Aspect Ventures, Benchmark, Malay Gandhi, Paul Levine
|